381 related articles for article (PubMed ID: 34625124)
21. Engineering Macrophages for Cancer Immunotherapy and Drug Delivery.
Xia Y; Rao L; Yao H; Wang Z; Ning P; Chen X
Adv Mater; 2020 Oct; 32(40):e2002054. PubMed ID: 32856350
[TBL] [Abstract][Full Text] [Related]
22. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
23. Tumor-Associated Macrophages as Target for Antitumor Therapy.
Sawa-Wejksza K; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):97-111. PubMed ID: 28660349
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
25. "Re-educating" Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma.
Liu KX; Joshi S
Front Immunol; 2020; 11():1947. PubMed ID: 32983125
[TBL] [Abstract][Full Text] [Related]
26. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
[TBL] [Abstract][Full Text] [Related]
27. Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk.
Sarode P; Schaefer MB; Grimminger F; Seeger W; Savai R
Front Oncol; 2020; 10():324. PubMed ID: 32219066
[TBL] [Abstract][Full Text] [Related]
28. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
29. The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.
Xu L; Xie X; Luo Y
Eur J Cell Biol; 2021 Mar; 100(2):151153. PubMed ID: 33476912
[TBL] [Abstract][Full Text] [Related]
30. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
[TBL] [Abstract][Full Text] [Related]
31. Molecular Repolarisation of Tumour-Associated Macrophages.
van Dalen FJ; van Stevendaal MHME; Fennemann FL; Verdoes M; Ilina O
Molecules; 2018 Dec; 24(1):. PubMed ID: 30577495
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology of tumor-associated macrophages.
Yuan A; Chen JJ; Yang PC
Adv Clin Chem; 2008; 45():199-223. PubMed ID: 18429498
[TBL] [Abstract][Full Text] [Related]
33. The Unique Molecular and Cellular Microenvironment of Ovarian Cancer.
Worzfeld T; Pogge von Strandmann E; Huber M; Adhikary T; Wagner U; Reinartz S; Müller R
Front Oncol; 2017; 7():24. PubMed ID: 28275576
[TBL] [Abstract][Full Text] [Related]
34. Combining epigenetic and immune therapy to overcome cancer resistance.
Gomez S; Tabernacki T; Kobyra J; Roberts P; Chiappinelli KB
Semin Cancer Biol; 2020 Oct; 65():99-113. PubMed ID: 31877341
[TBL] [Abstract][Full Text] [Related]
35. A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications.
Sedighzadeh SS; Khoshbin AP; Razi S; Keshavarz-Fathi M; Rezaei N
Transl Lung Cancer Res; 2021 Apr; 10(4):1889-1916. PubMed ID: 34012800
[TBL] [Abstract][Full Text] [Related]
36. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
37. Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment.
Koo J; Hayashi M; Verneris MR; Lee-Sherick AB
Front Oncol; 2020; 10():581107. PubMed ID: 33381449
[TBL] [Abstract][Full Text] [Related]
38. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
39. Activation of phagocytosis by immune checkpoint blockade.
Li CW; Lai YJ; Hsu JL; Hung MC
Front Med; 2018 Aug; 12(4):473-480. PubMed ID: 30062558
[TBL] [Abstract][Full Text] [Related]
40. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
